Saved in:
| Main Authors: | Bornkamp, Björn, Zaoli, Silvia, Azzarito, Michela, Martin, Ruvie, Müller, Carsten Philipp, Moloney, Conor, Capestro, Giulia, Ohlssen, David, Baillie, Mark |
|---|---|
| Format: | Preprint |
| Published: |
2023
|
| Subjects: | |
| Online Access: | https://arxiv.org/abs/2304.05658 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Predicting subgroup treatment effects for a new study: Motivations, results and learnings from running a data challenge in a pharmaceutical corporation
by: Björn Bornkamp, et al.
Published: (2024)
by: Björn Bornkamp, et al.
Published: (2024)
Assessment of evidence against homogeneity in exhaustive subgroup treatment effect plots
by: Bornkamp, Björn, et al.
Published: (2026)
by: Bornkamp, Björn, et al.
Published: (2026)
The Framework That Survives Bad Models: Human-AI Collaboration For Clinical Trials
by: Chen, Yao, et al.
Published: (2025)
by: Chen, Yao, et al.
Published: (2025)
WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
by: Sechidis, Konstantinos, et al.
Published: (2024)
by: Sechidis, Konstantinos, et al.
Published: (2024)
WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
by: Konstantinos Sechidis, et al.
Published: (2024)
by: Konstantinos Sechidis, et al.
Published: (2024)
Patrimônio, Cidade e o Papel do Desenho Urbano
by: Antonio Capestro
Published: (2021)
by: Antonio Capestro
Published: (2021)
Oggi la città
by: Capestro, Antonio
Published: (2022)
by: Capestro, Antonio
Published: (2022)
Progettando città
by: Capestro, Antonio
Published: (2022)
by: Capestro, Antonio
Published: (2022)
All that Glitters Is not Gold: Type‐I Error Controlled Variable Selection from Clinical Trial Data
by: Manuela R. Zimmermann, et al.
Published: (2024)
by: Manuela R. Zimmermann, et al.
Published: (2024)
Data-driven controlled subgroup selection in clinical trials
by: Müller, Manuel M., et al.
Published: (2025)
by: Müller, Manuel M., et al.
Published: (2025)
Evaluating causal effects on time-to-event outcomes in an RCT in Oncology with treatment discontinuation
by: Ballerini, Veronica, et al.
Published: (2023)
by: Ballerini, Veronica, et al.
Published: (2023)
Comparing methods to assess treatment effect heterogeneity in general parametric regression models
by: Chen, Yao, et al.
Published: (2025)
by: Chen, Yao, et al.
Published: (2025)
Randomization-based Inference for MCP-Mod
by: Pin, Lukas, et al.
Published: (2024)
by: Pin, Lukas, et al.
Published: (2024)
Futility analyses for the MCP-Mod methodology based on longitudinal models
by: Bornkamp, Björn, et al.
Published: (2024)
by: Bornkamp, Björn, et al.
Published: (2024)
Futility Analyses for the MCP ‐Mod Methodology Based on Longitudinal Models
by: Björn Bornkamp, et al.
Published: (2025)
by: Björn Bornkamp, et al.
Published: (2025)
Impact of an educational intervention utilising a three‐dimensional‐printed model for ultrasound‐guided intra‐articular injections of the dislocated shoulder
by: Conor Cosgrave, et al.
Published: (2024)
by: Conor Cosgrave, et al.
Published: (2024)
Osteoblastic metastasis secondary to mammary carcinoma in a dog ( Canis lupus familiaris ) presenting with lameness
by: David Sheehan, et al.
Published: (2025)
by: David Sheehan, et al.
Published: (2025)
The opportunities and challenges to introduce pharmaceutical care in Cuba
by: Martínez Sánchez, Alina de las Mercedes
Published: (2023)
by: Martínez Sánchez, Alina de las Mercedes
Published: (2023)
Using Individualized Treatment Effects to Assess Treatment Effect Heterogeneity
by: Sechidis, Konstantinos, et al.
Published: (2025)
by: Sechidis, Konstantinos, et al.
Published: (2025)
Evaluating Causal Effects on Time‐to‐Event Outcomes in an RCT in Oncology With Treatment Discontinuation
by: Veronica Ballerini, et al.
Published: (2025)
by: Veronica Ballerini, et al.
Published: (2025)
Using Individualized Treatment Effects to Assess Treatment Effect Heterogeneity
by: Konstantinos Sechidis, et al.
Published: (2025)
by: Konstantinos Sechidis, et al.
Published: (2025)
Comparing Methods to Assess Treatment Effect Heterogeneity in General Parametric Regression Models
by: Yao Chen, et al.
Published: (2026)
by: Yao Chen, et al.
Published: (2026)
Delivering medicines in a challenging environment: the pharmaceutical sector in East Timor (a descriptive study)
by: Pauline Norris
Published: (2007)
by: Pauline Norris
Published: (2007)
OSI: Will It Ever See the Light of Day?
by: Moloney, Peter
Published: (1997)
by: Moloney, Peter
Published: (1997)
Always a Manager? Assessing the Commission's Capacity to Manage and Deepen the Post‐Brexit EU–UK Relationship Whilst Expanding Its Competencies
by: David Moloney, et al.
Published: (2025)
by: David Moloney, et al.
Published: (2025)
Fun With Fourier Series
by: Baillie, Robert
Published: (2008)
by: Baillie, Robert
Published: (2008)
Symmetry and Self-Bound Droplets in Dipolar Molecular Gases
by: Baillie, D.
Published: (2025)
by: Baillie, D.
Published: (2025)
Summing the curious series of Kempner and Irwin
by: Baillie, Robert
Published: (2008)
by: Baillie, Robert
Published: (2008)
‘Action Needed’—The Critical Role of Peer Reviewers for Evidence‐Based Kidney Care
by: Jessica Baillie
Published: (2026)
by: Jessica Baillie
Published: (2026)
How stronger patent protection in India might affect the behavior of trasnational pharmaceutical industries / Carsten Fink
by: Fink, Carsten
Published: (2000)
by: Fink, Carsten
Published: (2000)
Response to “Comment on Development of a Novel Frailty Trigger for Use at Triage in the Emergency Department”
by: Elizabeth Moloney, et al.
Published: (2025)
by: Elizabeth Moloney, et al.
Published: (2025)
Removal of pharmaceuticals during drinking water treatment
Published: (2002)
Published: (2002)
Gender, Migration and Categorisation
by: Moloney, Deirdre M.
Published: (2025)
by: Moloney, Deirdre M.
Published: (2025)
Emotion Regulation in Procedural Medicine: From Suppression to Integration
by: Brian M. Moloney
Published: (2025)
by: Brian M. Moloney
Published: (2025)
Functional-Integral Based Perturbation Theory for the Malthus-Verhulst Process
by: Nicholas R. Moloney
Published: (2006)
by: Nicholas R. Moloney
Published: (2006)
Normal subgroups and permutation characters: a correction to a proof of Klingen
by: Muller, Peter, et al.
Published: (2025)
by: Muller, Peter, et al.
Published: (2025)
Standardization for safety: a feasible challenge
by: Silvia Manrique-Rodríguez
Published: (2020)
by: Silvia Manrique-Rodríguez
Published: (2020)
Motivations and challenges for M-Business Transformation: a multiple-case study
by: Heng-Sheng Tsai
Published: (2007)
by: Heng-Sheng Tsai
Published: (2007)
Origin of Phobos and Deimos : Orbital evolution shortly after formation from a potential dislocation
by: Dahoumane, Ryan, et al.
Published: (2025)
by: Dahoumane, Ryan, et al.
Published: (2025)
Rural health research in the 21st century: A commentary on challenges and the role of digital technology
by: Mairead Moloney, et al.
Published: (2024)
by: Mairead Moloney, et al.
Published: (2024)
Similar Items
-
Predicting subgroup treatment effects for a new study: Motivations, results and learnings from running a data challenge in a pharmaceutical corporation
by: Björn Bornkamp, et al.
Published: (2024) -
Assessment of evidence against homogeneity in exhaustive subgroup treatment effect plots
by: Bornkamp, Björn, et al.
Published: (2026) -
The Framework That Survives Bad Models: Human-AI Collaboration For Clinical Trials
by: Chen, Yao, et al.
Published: (2025) -
WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
by: Sechidis, Konstantinos, et al.
Published: (2024) -
WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
by: Konstantinos Sechidis, et al.
Published: (2024)